TY - JOUR
T1 - Specific somatoform disorder in the general population
AU - Grabe, Hans Joergen
AU - Meyer, Christian
AU - Hapke, Ulfert
AU - Rumpf, Hans Juergen
AU - Freyberger, Harald Juergen
AU - Dilling, Horst
AU - John, Ulrich
N1 - Funding Information:
This study is part of the German Research Network Analytical Epidemiology of Substance Abuse. Factors related to the use and abuse of psychoactive substances are analyzed by different research groups in the context of several longitudinal studies. Contact persons are Dr. Büringer and Dr. Küfner (IFT Institute for Therapy Research, Munich), Dr. Wittchen (Max-Planck-Institute, Munich), Dr. John (University of Greifswald, Greifswald, Germany), and Dr. Dilling (Medical University of Lübeck, Lübeck, Germany). The German Research Network is funded in the context of the Biological and Psychosocial Factors of Drug Abuse and Dependence by the Federal Ministry of Education , Science, Research, and Technology . Data described in this article are part of Transitions in Alcohol Consumption and Smoking, Part 1: Drug Use in the Adult General Population in a Northern German City and Surrounding Communities, grant 01EB9406 ; principal investigators are Dr. John and Dr. Dilling.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2003
Y1 - 2003
N2 - The authors assessed the validity of the recently proposed diagnosis for specific somatoform disorder in the general population. German versions of the DSM-IV adapted Composite International Diagnostic Interview were administered to a representative sample of 4,075 individuals. Multivariate analyses were used to compare impairment, life satisfaction, and use of health care. A total of 803 of 4,075 subjects (19.7%) with undifferentiated somatization disorder were identified, which included 51 subjects (1.3%) who met criteria for specific somatoform disorder. Subjects with specific somatoform disorder were more impaired, had lower life satisfaction, and had higher use of health care than subjects with undifferentiated somatization disorder only. The proposed diagnosis of specific somatoform disorder demonstrated a high validity independent of comorbid depressive and anxiety disorders.
AB - The authors assessed the validity of the recently proposed diagnosis for specific somatoform disorder in the general population. German versions of the DSM-IV adapted Composite International Diagnostic Interview were administered to a representative sample of 4,075 individuals. Multivariate analyses were used to compare impairment, life satisfaction, and use of health care. A total of 803 of 4,075 subjects (19.7%) with undifferentiated somatization disorder were identified, which included 51 subjects (1.3%) who met criteria for specific somatoform disorder. Subjects with specific somatoform disorder were more impaired, had lower life satisfaction, and had higher use of health care than subjects with undifferentiated somatization disorder only. The proposed diagnosis of specific somatoform disorder demonstrated a high validity independent of comorbid depressive and anxiety disorders.
UR - http://www.scopus.com/inward/record.url?scp=0037867077&partnerID=8YFLogxK
U2 - 10.1176/appi.psy.44.4.304
DO - 10.1176/appi.psy.44.4.304
M3 - Journal articles
C2 - 12832596
AN - SCOPUS:0037867077
SN - 0033-3182
VL - 44
SP - 304
EP - 311
JO - Psychosomatics
JF - Psychosomatics
IS - 4
ER -
